Efficacy of aripiprazole combined with olanzapine for hospitalized male patients with schizophrenia and its effect on metabolic syndrome

BackgroundSchizophrenia and the use of antipsychotic medications are identified to be the likely contributors to the development of metabolic syndrome (MS) and cardiovascular disease, and jeopardize the prognosis of schizophrenia. Therefore, effectively preventing or reducing the risk of developing...

Full description

Bibliographic Details
Main Authors: Liu Shunhua, Yuan Xiaofeng, Ye Xueting, Zhang Yuliang, Zhao Li, Zhou Kunyuan
Format: Article
Language:zho
Published: Editorial Office of Sichuan Mental Health 2024-06-01
Series:Sichuan jingshen weisheng
Subjects:
Online Access:http://www.psychjm.net.cn/scjswszzen/ch/reader/view_abstract.aspx?file_no=202403006&flag=1